Black women were more likely to benefit from neoadjuvant endocrine therapy for early-stage breast cancer, however, their outcomes were inferior to White women when it came to late-stage disease, ...
In an update of MINDACT in women with ER-positive, HER2-negative early-stage breast cancer and 0-3 axillary nodes involved with high clinical, low genomic risk, there was an adjuvant chemotherapy ...
The investigational, oral selective estrogen receptor degrader (SERD) giredestrant given as an adjuvant therapy showed significant improvement in invasive disease-free survival (iDFS) compared with ...
Chemotherapy (CT) de-escalation using an FDG-PET/CT (F-PET) and pathological response-adapted strategy in HER2[+] early breast cancer (EBC): PHERGain Trial. This is an ASCO Meeting Abstract from the ...
The administration of endocrine therapy for 5 years substantially reduces recurrence rates during and after treatment in women with early-stage, estrogen-receptor (ER)–positive breast cancer.
The endocrine system is the name for the glands that produce hormones in a person’s body. These glands include the thyroid gland, pituitary gland, and adrenal gland. The endocrine system produces ...
When these hormones become imbalanced, it can lead to the development of an endocrine disorder. “An endocrine disorder occurs when your body produces either too much or too little of a particular ...
The endocrine system uses chemical messengers called hormones to regulate a range of bodily functions through the release of hormones. The endocrine system is a network of glands and organs located ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results